80048594 - HematologyConsults.com: Emerging Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma



Date & Location
Wednesday, August 7, 2019, 12:00 AM - Friday, August 7, 2020, 12:00 AM

Target Audience
Specialties - Nurse Practitioner, Nursing, Oncology, Physician Assistant

Overview

This module will focus on the clinical management and the role of targeted- and immuno-oncology agents/regimens for RRMM, and anticipate participation to include a minimum of 1,000 hematology providers (at least 350 completed activities). The module will be part of the larger curriculum of online modules ? HematologyConsults.com ? a learning portal with modules that address knowledge, competence and clinical practice gaps among clinicians who care for patients with various hematological malignancies. Each module addresses a specific topic or tumor type, such as multiple myeloma, and may focus on particular subtypes or treatment approaches.

http://www.hematologyconsults.com/Home/CEData/801

Objectives
After attending this activity, the participant will demonstrate the ability to:

  1. Evaluate the different types of FDA-approved agents for RRMM and the current NCCN guidelines for treating patients with RRMM.
  2. Review the safety and efficacy of investigational targeted- and immuno-therapies for RRMM patients.
  3. Develop patient-specific treatment based on tumor features, patient characteristics, treatment history/response, frailty score and cytogenetic considerations.